Alinity m HCV
Device
Abbott Laboratories
Total Payments
$138,165
Transactions
10
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $117,609 | 6 | 0 |
| 2019 | $20,555 | 4 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $138,165 | 10 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Collection of Plasma and/or Serum Samples from Subjects infected with Chronic Hepatitis C Virus Genotype 1, 2 and 3 | Abbott Laboratories | $68,340 | 0 |
| PCORI HCV screening at methadone clinics across NY state | Abbott Laboratories | $49,269 | 0 |
| Abbott Molecular Alinity m HCV Testing Study | Abbott Laboratories | $11,140 | 0 |
| Abbott Molecular Alinity m HCV Reproducibility Study | Abbott Laboratories | $9,415 | 0 |
Top Doctors Receiving Payments for Alinity m HCV
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Rochester, MN | $138,165 | 10 |
Ad
Manufacturing Companies
- Abbott Laboratories $138,165
Product Information
- Type Device
- Total Payments $138,165
- Total Doctors 0
- Transactions 10
About Alinity m HCV
Alinity m HCV is a device associated with $138,165 in payments to 0 healthcare providers, recorded across 10 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2019 to 2020. In 2020, $117,609 was paid across 6 transactions to 0 doctors.
The most common payment nature for Alinity m HCV is "Unspecified" ($138,165, 100.0% of total).
Alinity m HCV is associated with 4 research studies, including "Collection of Plasma and/or Serum Samples from Subjects infected with Chronic Hepatitis C Virus Genotype 1, 2 and 3" ($68,340).